Harbor Investment Advisory, LLC Crispr Therapeutics Ag Transaction History

Harbor Investment Advisory, LLC

$1.26 Billion
Q4 2024

A detailed history of Harbor Investment Advisory, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Harbor Investment Advisory, LLC holds 4,455 shares of CRSP stock, worth $186,441. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,455

Previous 5,805 23.26%

Holding current value

$186,441

Previous $272,000 35.66%

% of portfolio

0.01%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	SELL	$38.65 - $55.15 $52,177 - $74,452	-1,350 Reduced 23.26%	4,455 $175,000
Q3 2024 Oct 04, 2024	SELL	$44.62 - $62.75 $892 - $1,255	-20 Reduced 0.34%	5,805 $272,000
Q2 2024 Jul 19, 2024	SELL	$51.17 - $68.18 $17,653 - $23,522	-345 Reduced 5.59%	5,825 $314,000
Q4 2023 Jan 26, 2024	SELL	$38.62 - $72.18 $17,379 - $32,481	-450 Reduced 6.8%	6,170 $386,000
Q3 2023 Oct 13, 2023	SELL	$45.39 - $59.0 $181 - $236	-4 Reduced 0.06%	6,620 $300,000
Q2 2023 Jul 14, 2023	SELL	$43.47 - $67.77 $23,908 - $37,273	-550 Reduced 7.67%	6,624 $371,000
Q1 2023 Apr 21, 2023	SELL	$41.0 - $56.12 $28,700 - $39,284	-700 Reduced 8.89%	7,174 $324,000
Q4 2022 Jan 24, 2023	SELL	$39.19 - $65.67 $127,367 - $213,427	-3,250 Reduced 29.22%	7,874 $0
Q3 2022 Nov 01, 2022	SELL	$61.1 - $83.78 $12,220 - $16,756	-200 Reduced 1.77%	11,124 $727,000
Q2 2022 Jul 18, 2022	SELL	$43.23 - $73.83 $2,161 - $3,691	-50 Reduced 0.44%	11,324 $688,000
Q1 2022 Apr 20, 2022	SELL	$53.19 - $79.24 $221,802 - $330,430	-4,170 Reduced 26.83%	11,374 $714,000
Q4 2021 Jan 10, 2022	SELL	$70.09 - $111.29 $37,147 - $58,983	-530 Reduced 3.3%	15,544 $1.18 Million
Q3 2021 Oct 12, 2021	SELL	$110.2 - $156.64 $35,264 - $50,124	-320 Reduced 1.95%	16,074 $1.8 Million
Q2 2021 Jul 27, 2021	BUY	$100.84 - $161.89 $35,294 - $56,661	350 Added 2.18%	16,394 $2.65 Million
Q1 2021 Apr 16, 2021	BUY	$110.72 - $210.04 $74,846 - $141,987	676 Added 4.4%	16,044 $1.96 Million
Q4 2020 Feb 04, 2021	BUY	$79.67 - $173.23 $248,570 - $540,477	3,120 Added 25.47%	15,368 $2.35 Million
Q3 2020 Oct 23, 2020	SELL	$78.5 - $100.64 $134,313 - $172,195	-1,711 Reduced 12.26%	12,248 $1.02 Million
Q2 2020 Jul 16, 2020	BUY	$38.5 - $76.05 $140,756 - $278,038	3,656 Added 35.48%	13,959 $1.03 Million
Q1 2020 May 11, 2020	BUY	$33.68 - $62.53 $27,078 - $50,274	804 Added 8.46%	10,303 $437,000
Q4 2019 Jan 16, 2020	BUY	$36.68 - $73.13 $348,423 - $694,661	9,499 New	9,499 $579,000

Others Institutions Holding CRSP

# of Institutions

487

Shares Held

58M

Call Options Held

1.09M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.26B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbor Investment Advisory, LLC with notifications on news.

Account

Harbor Investment Advisory, LLC Crispr Therapeutics Ag Transaction History